Pharmaceutical Industry Information Portal

HomeNews

News

Novavax Initiates Phase 1/2 Clinical Trial of Combination Vaccine for COVID-19 and Seasonal Influenza

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced enrollment of the first participants in...

Minister of Economic Development of the Russian Federation M. Reshetnikov took part in the launch of a production line at the Biokhimik plant of...

Maxim Reshetnikov visited the Biokhimik plant as part of acquaintance with the participants of the national project «Increasing labor productivity and supporting employment» which...

The launch of R&D centre at BratskChemSyntez LLC

The R&D centre is tasked to optimise its substance manufacturing process and develop new unique molecules. The complex has modern and high-precision equipment that allows...

EMA evaluating data on booster dose of COVID-19 vaccine Comirnaty

EMA has started evaluating an application for the use of a booster dose of Comirnaty to be given 6 months after the second dose...

Russian scientists developed intestinal soluble capsules

Crohn's disease and ulcerative colitis are severe chronic bowel diseases for which there are no effective drugs yet. The main approach in their therapy...

Grindeks invests 800 thousand euros in the creation of a multifunctional site

Joint-stock company “Grindeks” has invested 800 thousand euros in the site of production of active pharmaceutical ingredients (APIs) and installed new, state-of-the-art laboratories and...
spot_img

Expert Articles

spot_img